BiotechTube
Home/DAMONA Pharmaceuticals/Etienne Sibille, PhD
ES

Etienne Sibille, PhD

Scientific Founder

DAMONA Pharmaceuticals

Therapeutic Areas

Neurodegenerative diseasesPsychiatric disordersCognitive impairment

DAMONA Pharmaceuticals Pipeline

DrugIndicationPhase
DPX-101Cognitive deficits in Alzheimer’s disease and other CNS disordersPhase 1

Leadership Team at DAMONA Pharmaceuticals

JR
John Reilly
Chief Executive Officer
RR
Rob Risinger, MD
Consulting Chief Medical Officer
View full DAMONA Pharmaceuticals profile